Skip to main content
TipRanks
Go Ultimate75% OFF

Davis New York Venture Fund Cl R (NYVRX) Technical Analysis

Summary of all the Indicators

Summary
Strong SellStrong Buy
Buy
5Bearish
2Neutral
15Bullish
Oscillators
Strong SellStrong Buy
Sell
5Bearish
2Neutral
3Bullish
Moving Averages
Strong SellStrong Buy
Strong Buy
0Bearish
0Neutral
12Bullish

1 Day timeframe · Data as of Nov 13, 2026

  • Davis New York Venture Fd Cl R’s (NYVRX) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting Davis New York Venture Fd Cl R is a Sell.
  • Davis New York Venture Fd Cl R’s (NYVRX) 20-Day exponential moving average is 30.62, while Davis New York Venture Fd Cl R’s (NYVRX) share price is $31.09, making it a Buy.
  • Davis New York Venture Fd Cl R’s (NYVRX) 50-Day exponential moving average is 30.48, while Davis New York Venture Fd Cl R’s (NYVRX) share price is $31.09, making it a Buy.

Davis New York Venture Fd Cl R (NYVRX) Pivot Points

1 Day timeframe · Data as of Nov 13, 2026

NYVRX pivot points
NameS3S2S1Pivot PointsR1R2R3
Classic30.9830.9830.9830.9830.9830.9830.98
Fibonacci30.9830.9830.9830.9830.9830.9830.98

Davis New York Venture Fd Cl R (NYVRX) Moving Averages

1 Day timeframe · Data as of Nov 13, 2026

NYVRX moving averages
PeriodSimpleExponential
MA531.01Buy30.96Buy
MA1030.73Buy30.80Buy
MA2030.57Buy30.62Buy
MA5030.34Buy30.48Buy
MA10030.56Buy30.31Buy
MA20029.71Buy29.47Buy
  • Davis New York Venture Fd Cl R’s (NYVRX) 10-Day exponential moving average is 30.80, while Davis New York Venture Fd Cl R’s (NYVRX) share price is $31.09, making it a Buy.
  • Davis New York Venture Fd Cl R’s (NYVRX) 100-Day exponential moving average is 30.31, while Davis New York Venture Fd Cl R’s (NYVRX) share price is $31.09, making it a Buy.
  • Davis New York Venture Fd Cl R’s (NYVRX) stock price is $31.09 and Davis New York Venture Fd Cl R’s (NYVRX) 50-day simple moving average is 30.34, creating a Buy signal.
  • Davis New York Venture Fd Cl R’s (NYVRX) stock price is $31.09 and Davis New York Venture Fd Cl R’s (NYVRX) 100-day simple moving average is 30.56, creating a Buy signal.
  • Davis New York Venture Fd Cl R’s (NYVRX) stock price is $31.09 and Davis New York Venture Fd Cl R’s (NYVRX) 200-day simple moving average is 29.71, creating a Buy signal.

Davis New York Venture Fd Cl R (NYVRX) Technical Analysis

1 Day timeframe · Data as of Nov 13, 2026

NYVRX technical indicators
NameValueAction
RSI (14)63.13Neutral
STOCH (9,6)92.76Sell
STOCHRSI (14)93.63Sell
MACD (12,26)0.19Sell
ADX (14)14.95Buy
Williams %R-3.37Sell
CCI (14)136.20Sell
ATR (14)0.16-
Ultimate Oscillator62.85Neutral
ROC2.30Buy
  • Davis New York Venture Fd Cl R’s (NYVRX) Relative Strength Index (RSI) is 63.13, creating a Neutral signal.
  • Davis New York Venture Fd Cl R’s (NYVRX) Trend Strength Indicator (ADX) is 14.95, creating a Buy signal.
  • Davis New York Venture Fd Cl R’s (NYVRX) Commodity Channel Index (CCI) is 136.20, creating a Sell signal.
  • Davis New York Venture Fd Cl R’s (NYVRX) Price Rate of Change (ROC) is 2.30, creating a Buy signal.
Technical Analysis Screener.Customize your technical analysis to fit your
unique trading strategy with a flexible screener
Try it Now!

FAQ

Is NYVRX a Buy, Hold, or Sell?
Based on NYVRX’s technical indicators on the 1-day timeframe as of Nov 13, 2026, NYVRX is a Buy.
What is NYVRX’s RSI (14)?
NYVRX’s RSI (14) is 63.13, which suggests NYVRX is a Neutral.
What is NYVRX’s MACD?
NYVRX’s MACD is 0.19, which suggests NYVRX is a Sell.
What is NYVRX’s 5-day moving average?
NYVRX’s 5-day moving average is 31.01, which suggests NYVRX is a Buy.
What is NYVRX’s 20-day moving average?
NYVRX 20-day moving average is 30.57, which suggests NYVRX is a Buy.
What is NYVRX’s 50-day moving average?
NYVRX’s 50-day moving average is 30.34, which suggests NYVRX is a Buy.
What is NYVRX’s 200-day moving average?
NYVRX’s 200-day moving average is 29.71, which suggests NYVRX is a Buy.
What is NYVRX’s Williams % R (14)?
NYVRX’s Williams % R (14) is -3.37, which suggests NYVRX is a Sell.
What is NYVRX’s CCI (14)?
NYVRX’s CCI (14) is 136.20, which suggests NYVRX is a Sell.